Opioid Crisis Hidden Truths

FDA and DEA Opioid Crisis Defenses Under Fire: A Review

4 min · 29 mei 2026
aflevering FDA and DEA Opioid Crisis Defenses Under Fire: A Review artwork

Beschrijving

The opioid crisis: a public health concern with rising overdose deaths. This video explores addiction science, the role of Government Rules, and the impact law enforcement had. We'll discuss Narcan, treatments, and addiction's root causes like depression and PTSD. We'll examine criticisms of bureaucracy, CDC guidelines, and the history of opioid use, including the opium wars. Understanding fentanyl's lethality and neuroscience is key to combating this epidemic and supporting those affected.

Reacties

0

Wees de eerste die een reactie plaatst

Meld je nu aan en word lid van de Opioid Crisis Hidden Truths community!

Probeer gratis

Probeer 14 dagen gratis

€ 9,99 / maand na proefperiode. · Elk moment opzegbaar.

  • Podcasts die je alleen op Podimo hoort
  • 20 uur luisterboeken / maand
  • Gratis podcasts

Alle afleveringen

44 afleveringen

aflevering Ask the Right Questions: FDA Ombudsman and the Future of the OPIOID CRISIS artwork

Ask the Right Questions: FDA Ombudsman and the Future of the OPIOID CRISIS

The opioid crisis deeply impacts the US with rising overdose deaths fueled by fentanyl. We are tasked by the FDA with finding solutions to move past this OPIOID CRISIS!, and the FDA ombudsman plays a crucial, overlooked role. Examining opioid addiction science, brain models, and receptors can lead to solutions. Current guidelines may be insufficient, requiring bypassing bureaucracy for change. Observing near-death experiences and naloxone highlights the crisis's gravity. Rethinking our approach, with the FDA ombudsman key, combining law enforcement, neuroscience, and public health can create a future free from this crisis. Adrenaline and depression linked to addiction need a holistic approach using the latest science. FDA and CDC guidelines can form a framework for a new paradigm. The crisis's future depends on asking pertinent questions and seeking innovative solutions, with the FDA ombudsman integral.

Gisteren3 min